Vitamin D2 vs D3 vs D3 with K2: Which Form Should You Take?

D3 raises and holds blood vitamin D better than D2, and K2 is not required for D3 to work. What the trials show about D2, D3, and D3 with K2, and why your 25-hydroxyvitamin D result matters more than the label.

Published

January 28, 2026

Last updated

September 25, 2026

Read time

11 min read

Medically reviewed by

Rhonda Collins, FNP-C

Share

Copy link

The Short Answer: D2 vs D3, and D3 vs D3 with K2

Vitamin D2 vs D3: vitamin D3 (cholecalciferol) raises and maintains blood 25-hydroxyvitamin D more effectively than vitamin D2 (ergocalciferol). In a head-to-head trial, D3 was about 87% more potent than the same weekly dose of D2 [1].

Vitamin D3 vs D3 with K2: K2 is not needed for D3 to raise your vitamin D level [1]. The two are paired because vitamin K activates calcium-binding proteins in bone and blood vessels [6]. Outcome trials of K2 are mixed, and a two-year trial of K2 plus D in older men found no effect on heart valve calcification [7][8][13].

What decides the next step: your 25-hydroxyvitamin D blood result, not the bottle. A clinician uses that number to judge whether supplementing makes sense, and how much.

Vitamin D2 vs D3: What the Head-to-Head Trials Show

Vitamin D3 outperforms vitamin D2 at raising and holding 25-hydroxyvitamin D, the form of vitamin D measured in blood tests. Both forms are converted in the liver to 25-hydroxyvitamin D, so the difference shows up in how high that level rises and how long it stays up.

The two forms at a glance:

• Vitamin D2 (ergocalciferol): made by irradiating yeast or mushrooms. It is the form used in major prescription vitamin D preparations in North America [4].
• Vitamin D3 (cholecalciferol): the form your skin makes from sunlight. Supplement D3 is usually made from lanolin (sheep’s wool), and lichen-derived D3 exists for people who avoid animal products.

What the trials found:

• Heaney 2011: 33 healthy adults were given 50,000 IU of D2 or D3 once a week for 12 weeks. At steady state, 25-hydroxyvitamin D had risen by about 45 ng/mL in the D3 group and about 24 ng/mL in the D2 group. The authors estimated D3 was about 87% more potent and produced two to three times more vitamin D storage in fat [1].
• Armas 2004: 20 healthy men were given a single 50,000 IU dose of D2 or D3. Both produced a similar rise in 25-hydroxyvitamin D over the first three days. After that, levels kept rising with D3 and peaked at 14 days, while with D2 they fell back to baseline by day 14. The authors estimated D2’s potency at less than one third of D3’s [2].
• Tripkovic 2012 meta-analysis: pooling randomized trials, D3 raised 25-hydroxyvitamin D more than D2 overall. The advantage was clear when doses were given as large boluses, but the difference was not significant in trials of daily dosing [3].

So the gap between D2 and D3 is real, and it is largest with weekly or single large doses.

Why D3 Holds Blood Levels Better Than D2

The difference is not absorption. In the Armas trial, serum levels of the vitamin itself rose similarly after D2 and D3, which points to equivalent absorption [2]. The difference comes after absorption.

A 2006 review in the American Journal of Clinical Nutrition summarized the reasons: D2 metabolites bind less strongly to vitamin D binding protein in the blood, D2 is metabolized differently from D3, and D2 has a shorter shelf life [4]. Weaker binding is one proposed reason D2 does not hold blood levels as well, which fits the rapid fall in 25-hydroxyvitamin D seen after a single D2 dose [2].

For someone prescribed D2, this is a reason a follow-up blood result matters, not a reason to stop a prescribed treatment.

Vitamin D3 vs D3 with K2: What K2 Adds

Vitamin D3 works without K2. In the D2 vs D3 trials above, D3 was given on its own and raised 25-hydroxyvitamin D substantially [1][2]. The case for pairing them rests on what vitamin K does with calcium.

What K2 does. Vitamin K is a cofactor for activating (carboxylating) proteins that bind calcium, including osteocalcin in bone and matrix Gla protein in cartilage and the vessel wall [6]. Vitamin D helps regulate calcium absorption and balance [14], so the idea is that K2 helps make sure the proteins that handle calcium are fully activated.

What the evidence shows. K2 consistently changed these proteins in the trials below, with more activated osteocalcin or less inactive matrix Gla protein [7][8][9][12][13]. Whether that changes bones or arteries is less consistent:

• Bone: three years of MK-7 slowed age-related bone loss at the lumbar spine and femoral neck, but not the total hip, in healthy postmenopausal women [7]. One year of MK-7 did not change bone loss rates in early postmenopausal women [8]. In women with osteopenia, one year of MK-7 preserved bone structure at the shin but did not change bone density at any site [9].
• Arteries and heart valves: three years of MK-7 improved measures of arterial stiffness in healthy postmenopausal women [12]. In older men with aortic valve calcification, two years of MK-7 plus vitamin D did not slow calcification of the valve, aorta, or coronary arteries compared with placebo [13].

What this means for “D3 K2 benefits.” Evidence supports K2 changing vitamin K-dependent proteins. Evidence that D3 with K2 improves bone or heart outcomes beyond D3 alone is limited and mixed. No trial here shows that D3 without K2 causes calcium to build up in arteries.

How Much K2 With D3? What the Trials Used

The amounts below are what named trials used, not a recommendation. Most tested K2 on its own; the Rønn and Diederichsen trials paired it with vitamin D.

• Knapen 2013: 180 mcg of MK-7 daily for three years in 244 healthy postmenopausal women (bone outcomes) [7]. Knapen 2015 used the same amount for three years in 244 healthy postmenopausal women (arterial stiffness) [12].
• Emaus 2010: 360 mcg of MK-7 daily, from natto capsules, for one year in 334 early postmenopausal women. No effect on bone loss [8].
• Rønn 2016: 375 mcg of MK-7 daily for one year in 148 postmenopausal women with osteopenia, all also given calcium and vitamin D [9].
• Diederichsen 2022: 720 mcg of MK-7 plus 25 mcg of vitamin D daily for two years in 365 men with aortic valve calcification. No effect on calcification [13].
• Knapen 2007: 45 mg of MK-4 daily for three years in 325 postmenopausal women. Bone mineral content and femoral neck width improved, but DXA bone density did not [10].

Vitamin K also matters for blood clotting. A study of MK-7 supplements warned that intakes of 50 mcg a day or more may interfere with warfarin and similar anticoagulants in a clinically relevant way [6]. If you take one of these medicines, talk with your prescriber before using any vitamin K product.

MK-4 vs MK-7

MK-4 and MK-7 are the two forms of K2 in supplements, and they behave differently in the blood:

• MK-7 has a very long half-life, so blood levels stay stable and build up with daily intake [6]. In a study of healthy women, a single 420 mcg dose of MK-7 was detectable in blood for up to 48 hours [11].
• MK-4 at the same 420 mcg dose was not detectable in blood at any time point in that study, and 60 mcg a day for a week did not raise blood MK-4 [11]. The MK-4 bone trial cited here used a much larger amount, in milligrams [10].

Your 25-Hydroxyvitamin D Result, Not the Bottle, Decides the Next Step

The blood test for vitamin D status measures 25-hydroxyvitamin D. It is the circulating form made from both D2 and D3, so it reflects sun, food, and supplements together. Two people taking the same product can end up at very different levels, which is why the result says more than the label.

Testing is not something everyone needs. The Endocrine Society’s 2024 guideline found no trial evidence supporting routine 25-hydroxyvitamin D screening in the general population, including people with obesity or darker skin. It suggests against routine testing when there is no established reason for it. It also found no clear evidence defining an optimal 25-hydroxyvitamin D target for disease prevention [5]. That guideline does not apply to people with an established reason for vitamin D testing or treatment.

A result is most useful when it will change a decision:

• A known reason for low vitamin D, such as a condition that affects absorption, or a clinician’s plan to treat.
• Before supplementing above typical intakes. The same guideline suggests against empiric vitamin D above the Dietary Reference Intakes to lower disease risk in healthy adults under 75 [5].
• On prescription D2. Because 25-hydroxyvitamin D can fall quickly after D2 [2], a follow-up result shows whether the treatment is working.
• After a change, to see how your level responded.

Total vs fractionated tests. A standard 25-hydroxy vitamin D test reports one total. A 25-hydroxy vitamin D test with D2 and D3 reports the total plus 25-hydroxy D2 and 25-hydroxy D3 separately. The split is useful if you take prescription D2 and want to see how much each form contributes.

With Mito, every result is reviewed by a clinician. If you want vitamin D alongside a broader view, including calcium and magnesium, the Mito Core Panel includes 25-hydroxyvitamin D.

Photo from Unsplash

Magnesium, Dose, and Timing: Short Answers

Magnesium. The enzymes that convert vitamin D into its active forms appear to require magnesium as a cofactor [14]. For how the two nutrients interact and what the research shows, see magnesium and vitamin D synergy.

How much vitamin D. The right amount depends on your starting level, body size, absorption, and health history, so this guide does not give dose tiers. For reference intakes and how they are set, see how much vitamin D you should really take.

Timing. Vitamin D is fat-soluble. In a small study of 17 patients whose levels had not risen on treatment, taking their usual supplement with the largest meal of the day was followed by an average 57% rise in 25-hydroxyvitamin D after two to three months [15]. The study had no control group.

Key Takeaways

• D2 vs D3: D3 raised 25-hydroxyvitamin D more than D2 in head-to-head trials, with the clearest gap when large doses were given weekly or once [1][2][3].
• Why: D2 is absorbed as well as D3, but 25-hydroxyvitamin D falls faster after D2. Weaker binding of D2 metabolites to vitamin D binding protein is one proposed reason [2][4].
• D3 vs D3 with K2: D3 works without K2. K2 activates calcium-binding proteins, but outcome trials of K2 are mixed, and K2 plus D did not slow valve calcification in older men [6][7][8][13].
• K2 amounts in trials: MK-7 studies used 180 to 720 mcg a day. The MK-4 bone trial used 45 mg a day [7][8][9][10][13].
• Test with a reason: routine screening is not recommended for everyone, but when you have a reason to test, the 25-hydroxyvitamin D result is what informs the next step [5].

Track Your Progress

• Vitamin D
• Symptoms of Low Vitamin D
• How to Improve Your Vitamin D Level Naturally

Related Content

• Raising Vitamin D Levels Naturally: 7 Science-Backed Methods
• Magnesium with Vitamin D: The Essential Synergy
• Vitamin D Supplements: How Much Should You Really Take?
• Are Vitamins and Supplements HSA or FSA Eligible?

References

[1] Heaney RP, Recker RR, Grote J, Horst RL, Armas LA. Vitamin D3 is more potent than vitamin D2 in humans. J Clin Endocrinol Metab. 2011;96(3):E447-E452. PMID: 21177785

[2] Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004;89(11):5387-5391. PMID: 15531486

[3] Tripkovic L, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357-1364. PMID: 22552031

[4] Houghton LA, Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr. 2006;84(4):694-697. PMID: 17023693

[5] Demay MB, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024;109(8):1907-1947. PMID: 38828931

[6] Schurgers LJ, et al. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 2007;109(8):3279-3283. PMID: 17158229

[7] Knapen MH, et al. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013;24(9):2499-2507. PMID: 23525894

[8] Emaus N, et al. Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial. Osteoporos Int. 2010;21(10):1731-1740. PMID: 19937427

[9] Rønn SH, et al. Vitamin K2 (menaquinone-7) prevents age-related deterioration of trabecular bone microarchitecture at the tibia in postmenopausal women. Eur J Endocrinol. 2016;175(6):541-549. PMID: 27625301

[10] Knapen MH, Schurgers LJ, Vermeer C. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int. 2007;18(7):963-972. PMID: 17287908

[11] Sato T, Schurgers LJ, Uenishi K. Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutr J. 2012;11:93. PMID: 23140417

[12] Knapen MH, et al. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial. Thromb Haemost. 2015;113(5):1135-1144. PMID: 25694037

[13] Diederichsen ACP, et al. Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial. Circulation. 2022;145(18):1387-1397. PMID: 35465686

[14] Uwitonze AM, Razzaque MS. Role of Magnesium in Vitamin D Activation and Function. J Am Osteopath Assoc. 2018;118(3):181-189. PMID: 29480918

[15] Mulligan GB, Licata A. Taking vitamin D with the largest meal improves absorption and results in higher serum levels of 25-hydroxyvitamin D. J Bone Miner Res. 2010;25(4):928-930. PMID: 20200983